Malaysia
# |
Name |
Operating Cash Flow |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 743.77 M
|
Dec. 31, 2023 | USD 1.63 | -0.31% |
|
Malaysia |
|
2 |
USD 143.01 M
|
Dec. 31, 2023 | USD 0.54 | -0.31% |
|
Malaysia |
|
3 |
USD 13.75 M
|
June 30, 2024 | USD 1.01 | 2.66% |
|
Malaysia |
|
4 |
USD 11.21 M
|
Dec. 31, 2023 | USD 0.28 | -0.31% |
|
Malaysia |
|
5 |
USD -2.00 M
|
Dec. 31, 2023 | USD 1.40 | -2.10% |
|
Malaysia |
|
6 |
USD -52.38 M
|
June 30, 2024 | USD 0.27 | -0.31% |
|
Malaysia |
The Pharmaceuticals company in Malaysia with the highest Operating Cash Flow is IHH Healthcare Berhad (Kuala Lumpur Stock Exchange: 5225.KL) at USD 743.77 M.
The Pharmaceuticals company in Malaysia with the lowest Operating Cash Flow is Supermax Corporation Berhad (Kuala Lumpur Stock Exchange: 7106.KL) at USD -52.38 M.
The top 10 Pharmaceuticals companies in Malaysia by Operating Cash Flow are IHH Healthcare Berhad, KPJ Healthcare Berhad, Kotra Industries Berhad, Duopharma Biotech Berhad, Agape ATP Corporation and Supermax Corporation Berhad.
The bottom 10 Pharmaceuticals companies in Malaysia by Operating Cash Flow are Supermax Corporation Berhad, Agape ATP Corporation, Duopharma Biotech Berhad, Kotra Industries Berhad, KPJ Healthcare Berhad and IHH Healthcare Berhad.